Frontlight ResearchEarly access
Taking people in United StatesNo phase
Collecting tissue and blood samples from adults with melanoma for research
Collects tissue and blood samples from adults with melanoma to study disease growth.
Key facts
- Who runs it
- Vanderbilt-Ingram Cancer Center
- Where
- Nashville, United StatesSee the site
- Trial code
- Registry title
- Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
- Status
- Recruiting
- People taking part
- 3,000 people, planned
- Started
- 3 Jun 2010
- Expected to end
- Jun 2027
- Type of study
- Observational
- Treatments tested
- Tissue and blood collection
- Record updated
- 19 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a melanoma diagnosis confirmed under the microscope. Tissue and blood are collected and stored for research.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Melanoma confirmed by pathology (examination of tissue).
- Earlier treatment
- Not required. People who already had a diagnostic or treatment procedure can join if they have not yet been asked to take part.
Main reasons for not taking part
- Significant reasons that make drawing blood unsafe, such as severe anemia (these people can still join if they give a tissue block or 10-15 unstained slides)
- Unable or unwilling to give consent
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Pathologically-proven diagnosis of melanoma
- Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible
Who cannot take part
- Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol
- Any patient unable or unwilling to provide consent
Where in United States
- Vanderbitl-Ingram Cancer CenterNashville, United StatesContact: Vanderbilt-Ingram Service for Timely AccessTaking people
About the trial
What the trial wants to find out
The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.
Treatments tested
- Tissue and blood collection
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Plain-language title
- Collecting tissue and blood samples from adults with melanoma for researchGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Record updated
- 19 September 2025